BERGER FRANKLIN M exercised options at ATEA PHARMACEUTICALS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 6/24/2025ACC: 0000950170-25-089606
Director
Since Oct 2020
+70.80K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
100.40K acquired · 29.60K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+29.60K
Price / share
—
Trade value
—
% of position
6.2%
6/20/2025
476.90K→506.50K
Total
Net shares
+29.60K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/20/2025 | M · Option Exercise | +29.60K | — | — | 6.2% | 476.90K | 506.50K |
| Total | +29.60K | $0.00 | ||||||
Derivative Transactions3
Restricted Stock Units
Direct
Converts to
Common Stock
29.60K shares
Shares
+29.60K
Strike price
Held after
29.60K
Exercisable
—
6/20/2025
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
41.20K shares
Shares
+41.20K
Strike price
3.25
Held after
41.20K
Exercisable
—
6/20/2025
Restricted Stock Units
Direct
Converts to
Common Stock
29.60K shares
Shares
−29.60K
Strike price
Held after
0.00
Exercisable
—
6/20/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock29.60K shares | 6/20/2025 | A · Award | +29.60K | — | 29.60K | |
| Stock Option (Right to Buy) Direct | Common Stock41.20K shares | 6/20/2025 | A · Award | +41.20K | 3.25 | — | 41.20K |
| Restricted Stock Units Direct | Common Stock29.60K shares | 6/20/2025 | M · Option Exercise | −29.60K | — | 0.00 |